Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Before you blame your expanding waistline on your ...

Dr. Moawad is a neurologist and expert in brain health. She regularly writes and edits health content for medical books and publications. Supplements containing protein are recommended for people who ...

As black-market drugs go mainstream and legalization is within reach, entrepreneurs, investors and healthcare players are racing to cash in.

A new systematic review and meta-analysis suggests that increasing (and maintaining) step counts to around 8,500 steps a day is helpful for maintaining significant weight loss long term. Experts say ...

For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely be the weight they ...

Eli Lilly on May 21 said its experimental weight-loss shot retatrutide delivered dramatic weight loss in a late-stage study of people with obesity. Lilly said people on the next-generation weight loss ...

Retatrutide, a powerful experimental weight-loss drug that mimics three different hormones the body produces after eating, helped people lose 70 pounds on average, or 28% of their body weight, ...

Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins An experimental shot helped participants ...

The next generation of glucagonlike peptide 1 (GLP-1) weight-loss drugs has taken another step forward to U.S. Food and Drug Administration approval. In new clinical trial results from the ...